Associate Professor

The petition was approved based on a Ph.D. in medicinal chemistry and a record of 20 peer-reviewed scientific articles and 3 patent applications. His work garnered 237 citations from researchers in at least 33 countries, demonstrating sustained international acclaim. Additionally, he satisfied the judging criterion by conducting at least 20 manuscript reviews for highly discerning journals.

The petition was approved based on an extensive record of 215 peer-reviewed journal articles, 6 conference papers, 10 preprints, 15 book chapters, 5 books, and 41 patent applications. The petitioner also demonstrated significant influence through over 140 peer reviews for major journals and a high citation impact. These metrics satisfied the EB-1A criteria for scholarly articles, judging, and original contributions of major significance.

The petition was approved based on meeting at least three EB-1A criteria: authorship of scholarly articles, participation as a judge of others' work, and original scientific contributions of major significance. Specific metrics included 34 journal articles in high-impact venues like Cell Chemical Biology, 1,306 citations with an h-index of 17, and over 25 completed manuscript reviews. Evidence of the commercialization of key compounds further demonstrated the petitioner's extraordinary ability.

The approval was based on a significant publication record of 28 journal articles and a citation count exceeding 360, placing the petitioner in the top 1% of his field. Additionally, his 25 peer reviews and original contributions to antimicrobial and antidiabetic agents satisfied the EB-1A criteria.